Fixed Combination Antiemetic: A Literature Review on Prevention of Chemotherapy-Induced Nausea and Vomiting Using Netupitant/Palonosetron
- PMID: 29547597
- DOI: 10.1188/18.CJON.E52-E63
Fixed Combination Antiemetic: A Literature Review on Prevention of Chemotherapy-Induced Nausea and Vomiting Using Netupitant/Palonosetron
Abstract
Background: Prevention of chemotherapy-induced nausea and vomiting (CINV) can be improved with guideline-consistent use of antiemetics. However, adherence to antiemetic guidelines remains often insufficient. Therefore, new strategies that improve adherence are needed.
Objectives: To review the latest antiemetic guideline recommendations and provide an update on the use of NEPA, a fixed combination antiemetic composed of the neurokinin-1 receptor antagonist (RA) netupitant and the 5-hydroxytryptamine-3 RA palonosetron (Akynzeo®).
Methods: Analysis of the literature was performed, including guidelines, published literature, congress data on NEPA, and relevant articles on CINV.
Findings: Nurses are in a unique position to promote guideline-consistent antiemetic prophylaxis and are central in the education of patients and caregivers. Thus, nurses’ continuous education on antiemetic treatments is key for the prevention and management of CINV. NEPA offers a simplified antiemetic therapy with the potential to increase guideline adherence.
Keywords: NEPA; antiemetic guidelines; chemotherapy-induced nausea and vomiting.
Similar articles
-
Preventing chemotherapy-induced nausea and vomiting with netupitant/palonosetron, the first fixed combination antiemetic: current and future perspective.Future Oncol. 2019 Apr;15(10):1067-1084. doi: 10.2217/fon-2018-0872. Epub 2019 Mar 12. Future Oncol. 2019. PMID: 30860400
-
Cost-effectiveness of a fixed combination of netupitant and palonosetron (NEPA) relative to aprepitant plus granisetron (APR + GRAN) for prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a trial-based analysis.Support Care Cancer. 2020 Feb;28(2):857-866. doi: 10.1007/s00520-019-04824-y. Epub 2019 Jun 3. Support Care Cancer. 2020. PMID: 31161436 Free PMC article.
-
Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3-day aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study.Cancer Med. 2020 Jul;9(14):5134-5142. doi: 10.1002/cam4.3123. Epub 2020 May 30. Cancer Med. 2020. PMID: 32472742 Free PMC article. Clinical Trial.
-
Netupitant-palonosetron (NEPA) for Preventing Chemotherapy-induced Nausea and Vomiting: From Clinical Trials to Daily Practice.Curr Cancer Drug Targets. 2022;22(10):806-824. doi: 10.2174/1568009622666220513094352. Curr Cancer Drug Targets. 2022. PMID: 35570542 Free PMC article. Review.
-
A Review of NEPA, a Novel Fixed Antiemetic Combination with the Potential for Enhancing Guideline Adherence and Improving Control of Chemotherapy-Induced Nausea and Vomiting.Biomed Res Int. 2015;2015:651879. doi: 10.1155/2015/651879. Epub 2015 Sep 3. Biomed Res Int. 2015. PMID: 26421300 Free PMC article. Review.
Cited by
-
Improving Nausea and Vomiting Post-Elipse Balloon: a Novel Single-Dose Regimen of 300 mg Netupitant/0.5 mg Palonosetron Hydrochloride.Obes Surg. 2019 Sep;29(9):2952-2956. doi: 10.1007/s11695-019-03937-x. Obes Surg. 2019. PMID: 31104280 Clinical Trial.
-
Portuguese consensus on the prevention and treatment of nausea and vomiting induced by cancer treatments.Porto Biomed J. 2023 Oct 16;8(5):e234. doi: 10.1097/j.pbj.0000000000000234. eCollection 2023 Sep-Oct. Porto Biomed J. 2023. PMID: 37846304 Free PMC article. Review.
-
Retrospective Evaluation of a Dexamethasone Sparing Antiemetic Regimen: An Antiemetic Prophylaxis Study on NEPA (Netupitant Plus Palonosetron) for Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in Cancer Patients.Cureus. 2023 Nov 30;15(11):e49763. doi: 10.7759/cureus.49763. eCollection 2023 Nov. Cureus. 2023. PMID: 38161895 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
